Labshake search
Citations for Tocris :
301 - 350 of 1069 citations for 3 4 Ethoxy 3 methoxy phenyl 3 thiophene 2 carbonyl amino propionic acid since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Developmental Biology 2024Quote: ... This CBRa media consists of cSFDM containing 3 μm CHIR99021 (Tocris, No.4423), 10 ng/mL rhBMP4 (R&D ...
-
bioRxiv - Bioengineering 2023Quote: ... supplemented with Y-27632 (Tocris, cat# 1254, 5 µM, 24 h, day –3). On days 0 and 1 ...
-
bioRxiv - Neuroscience 2023Quote: ... The craniotomy was then covered with 3% agar (MilliporeSigma) dissolved in aCSF (TOCRIS). The agar was covered with silicone oil (60,000 centistokes ...
-
bioRxiv - Cell Biology 2024Quote: ... Midbrain patterning was achieved with the addition of 3 µM CHIR99021 (Tocris 4423), 2 µM purmorphamine (Stemcell 72204) ...
-
bioRxiv - Cell Biology 2024Quote: ... 1 μM PD0325901 (Stemgent, 04-0006) and 3 μM CHIR99021 (Tocris, 4423-10), as well as serum and LIF ...
-
bioRxiv - Neuroscience 2024Quote: ... All astrocyte calcium imaging experiments were performed with 3 μM TTX (Tocris, 1078) to block neuronal activity ...
-
bioRxiv - Genomics 2020Quote: ... supplemented with SMAD inhibitors (DMH-1 2 μM Tocris, Cat.: #4423; SB431542-10 μM Tocris, Cat.: #1614 and CHIR99021 3 μM, CHIR Tocris, Cat.: #4423).
-
bioRxiv - Neuroscience 2021Quote: ... d-2-Amino-5-phosphonovaleric acid (d-AP5, 50µM) and the sodium (Na+) channel blocker tetrodotoxin (TTX, 1 µM Tocris). Individual traces (5 sec duration ...
-
bioRxiv - Neuroscience 2020Quote: ... 20 μM 6,7-dinitroquinoxaline-2,3-dione (DNQX) and 20 μM D-(-)-2-amino-5-phosphopentanoic acid (D-AP5) (Tocris Bioscience) to block glycine- ...
-
bioRxiv - Neuroscience 2021Quote: ... SR95531 (gabazine) and 4-methoxy-7-nitroindolinyl-caged-L-glutamate (MNI-caged glutamate) were purchased from Tocris Bioscience (Bristol ...
-
bioRxiv - Neuroscience 2022Quote: 5-[2-Chloro-6-(trifluoromethoxy)phenyl]-1,3-dihydro-2H-benzimidazol-2-one (JNJ-5; Tocris, Minneapolis, MN) is a high affinity ...
-
bioRxiv - Cancer Biology 2021Quote: ... the positive control consisted of a treatment with 1 μM 3-AP (#2251; Tocris) for 72 h.
-
bioRxiv - Molecular Biology 2020Quote: Wild type zebrafish were exposed to 3 μM JWH-018 (Tocris, Cat. No. 1342), from 24 hours to six days post fertilization (dpf) ...
-
bioRxiv - Developmental Biology 2023Quote: ... but on day 3 medium was changed for LY (1 µM LPA (Tocris, 3854) and 10 µM ROCKi Y27632 ...
-
bioRxiv - Cell Biology 2023Quote: ... For the next 3 days CDBM with 0,6U/ml heparin and 3mM IWP2 (Tocris) was refreshed daily ...
-
bioRxiv - Neuroscience 2023Quote: ... mice were intraperitoneally injected with either 3 mg per kg of scopolamine hydrobromide (Tocris) dissolved in saline or vehicle (saline) ...
-
bioRxiv - Neuroscience 2024Quote: ... postsynaptic pharmacology experiments utilized nAChR antagonists dihydro-β-erythroidine hydrobromide (DHβE, 3 μM, Tocris) and methyllycaconitine (MLA ...
-
bioRxiv - Bioengineering 2024Quote: ... On day 3 the culture was treated with 5 μM IWP2 (3533, Tocris Bioscience) diluted in RPMI-B27 minus insulin and incubated for a further 48 hours ...
-
bioRxiv - Neuroscience 2024Quote: ... evaluation of D-amphetamine-induced hyperlocomotion (D-amphetamine sulfate, 3 mg/kg; TOCRIS 2813), were both evaluated in the open field as described elsewhere (Sancho-Balsells et al. ...
-
bioRxiv - Neuroscience 2020Quote: ... During BQA experiments the ACSF solution contained the following substances: 10 μM D-(−)-2-Amino-5-phosphonopentanoic acid (D-AP5) (Tocris), 10 μM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX ...
-
bioRxiv - Neuroscience 2021Quote: ... Amyloid plaques were stained by the β-sheet dye Methoxy-X04 (4 μg/ml in 50% ethanol, Tocris) for 30 min at RT and contrasting in 50% ethanol ...
-
bioRxiv - Neuroscience 2024Quote: ... neurofibrillary tangles and related AD pathological structures were additionally stained using 1 µM 4,4’-[(2-methoxy-1,4-phenylene) di-(1E)-2,1-ethenediyl] bisphenol (MX-04) (Tocris) for 15 minutes at room temperature ...
-
bioRxiv - Neuroscience 2021Quote: ... we used methoxy-X04 (TOCRIS, Bristol, United Kingdom) at a dilution of 0.01 mg/ml in the same slice as for NAB228 staining ...
-
bioRxiv - Neuroscience 2021Quote: ... and 250 μg of Methoxy-X04 (4920, Tocris) for staining amyloid plaque.
-
bioRxiv - Neuroscience 2022Quote: ... injection of 5 mg/kg Methoxy-X04 (Tocris) in 10% w/v DMSO containing phosphate-buffered saline ...
-
bioRxiv - Neuroscience 2021Quote: Varenicline or 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino[2,3-h] [3]benzazepine tartrate (Tocris, UK) was dissolved in sterile 0.9% physiological saline for a final dose of 1 mg/kg free base ...
-
bioRxiv - Neuroscience 2021Quote: ... some slices were incubated at 37°C with 3 µM puromycin (Tocris #40-895-0) at 65-75 minutes post-slicing ...
-
bioRxiv - Neuroscience 2022Quote: ... with the addition of either 3 μM or 10 mM GABA (Tocris; Cat. No. 0344). Sylgard 184 (Dow Corning ...
-
bioRxiv - Neuroscience 2021Quote: AM251 pharmacology: in experiments using the CB1 antagonist AM251 (3 µM) (Tocris and AdooQ biosciences), the drug (diluted in DMSO ...
-
bioRxiv - Neuroscience 2020Quote: ... with either 3 mg/kg clozapine N-oxide (CNO; Tocris, Catalog: 4936, Lot: 13D/233085) in 0.5% DMSO and saline ...
-
bioRxiv - Neuroscience 2022Quote: ... mEPSCs were recorded in the presence of 3 μM AMPA receptor antagonist NBQX (Tocris Bioscience) in standard external solution.
-
bioRxiv - Developmental Biology 2023Quote: ... N6,2’-O-Dibutyryladenosine 3’,5’-cyclic monophosphate sodium salt (DB-cAMP, TOCRIS Cat. No.: 1141), 8-(4-Chlorophenylthio)-N6-phenyladenosine-3’,5’-cyclic monophosphate sodium salt (8C6P-cAMP ...
-
bioRxiv - Cell Biology 2023Quote: ... the CDBM medium was supplemented with 0.6 U/ml heparin and 3 mM IWP2 (Tocris) for another 3-day incubation with medium refreshed daily ...
-
bioRxiv - Molecular Biology 2024Quote: ... AML12 cells at 70% confluency were treated with 3 μM CHIR99021 (cat. no. 4423; Tocris) for 48h ...
-
bioRxiv - Neuroscience 2024Quote: ... each animal underwent 3 consecutive trials before and after treatment with prazosin (7.5mg/kg, Tocris Biosciences ...
-
bioRxiv - Cell Biology 2024Quote: ... 10 mM 3-methyladenine (3MA, diluted directly into cell culture medium at 10mM; Tocris, 3977), 2.5 µM brefeldin A (diluted from 25mM stock prepared in DMSO ...
-
bioRxiv - Neuroscience 2021Quote: ... NMDA receptor (R) dependency was tested by application of an NMDAR antagonist (APV 50 µM, DL-2-Amino-5-phosphonopentanoic acid, Tocris, Germany) in the bath solution ...
-
bioRxiv - Neuroscience 2022Quote: ... containing 10 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 50 μM D,L-2-amino-5-phosphonovaleric acid (AP5) (both from Tocris, Bristol, UK) to block recurrent glutamatergic signaling.
-
bioRxiv - Neuroscience 2023Quote: ... The following compounds were added to raCSF as indicated in the Results section: D-(-)-2-Amino-5-phosphonopentanoic acid (D-APV, 100 μM dissolved in H2O; Tocris Bioscience), (5S,10R)-(+)-5-Methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine maleate (MK-801 ...
-
bioRxiv - Neuroscience 2023Quote: ... L-glutamate was locally photo-released from 1 mM 4-Methoxy-7-nitroindolinyl-caged-L-glutamate (MNI-glutamate, TOCRIS) using an OPTOLED pulse of 1 ms at 365 nM wavelength ...
-
bioRxiv - Neuroscience 2020Quote: ... and with Methoxy X04 (5 μM) (Tocris Bioscience #4920) or DAPI (300 nM ...
-
bioRxiv - Neuroscience 2020Quote: ... containing 10 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 50 μM D,L-2-amino-5-phosphonovaleric acid (AP5) to block glutamatergic signaling (both from Tocris, Bristol, UK). Experiments involving tetrodotoxin (TTX ...
-
bioRxiv - Developmental Biology 2021Quote: ... From passage 3 cells were grown NMP differentiation medium supplemented with 5 μM Y-27632 (Tocris). Human iPSCs were found to detach more readily than hESCs ...
-
bioRxiv - Developmental Biology 2020Quote: ... short-term serum-free culture was carried out in N2B27 supplemented with 3 μM CHIR99201 (Tocris), 1 μg/ml of Heparin (Sigma ...
-
bioRxiv - Developmental Biology 2020Quote: ... mTeSR Plus was replaced with the N2B27 basal medium supplemented with 3 μM CHIR99021 (Tocris Bioscience) and 40 ng/ml basic fibroblast growth factor bFGF/FGF2 (R&D Systems) ...
-
bioRxiv - Neuroscience 2020Quote: ... each disk with neurons was transferred into the physiological saline solution containing NBQX (3 μM, Tocris) and bicuculine (30 μM ...
-
bioRxiv - Bioengineering 2021Quote: ... Plates were centrifuged at 100xg for 3 minutes in E8 medium containing 10 μM Y27632 (Tocris). The following day ...
-
bioRxiv - Neuroscience 2023Quote: ... KA (3 mg/mL) was prepared on the day of experimentation by dissolving KA (Tocris, 0222) in a 0.9% bacteriostatic saline solution ...
-
bioRxiv - Neuroscience 2023Quote: The neural activity was reversibly suppressed using the GABA-A agonist 4,5,6,7-tetrahydro isoxazole [5,4-c]-pyridine-3-ol (THIP hydrochloride; Tocris). The THIP was dissolved in phosphate-buffered saline (PBS) ...
-
bioRxiv - Neuroscience 2021Quote: Structural plasticity of dendritic spines was stimulated through uncaging of 4-Methoxy-7-nitroindolinyl-caged-L-glutamate (MNI-caged glutamate, Tocris) using a Ti ...